Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine [Phase 1, Phase 2]

View source ↗

Summary

This notice reports that Sinocelltech Ltd. is conducting a Phase 1/2 trial to evaluate the safety, tolerability, and immunogenicity of a recombinant respiratory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Recombinant RSV vaccine (RSV vaccine, recombinant)

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Respiratory Syncytial Virus | Phase 1, Phase 2 | Status: RECRUITING